Research-stage natural product platform based on extracts and isolated compounds from Inula confertiflora, including carabrone, carpesiolin, and graviolide. Initial in vitro results indicate promising bioactivity, with in vivo validation and compound isolation planned to advance toward defined applications.
This offering centers on a natural product research platform built around the plant Inula confertiflora and related botanical sources. The work targets a family of bioactive compounds, including carabrone, carpesiolin, and graviolide, along with undefined extract components that have shown encouraging activity in initial laboratory screening. The program is designed to move from preliminary in vitro observations toward validated in vivo performance and, where feasible, the isolation and characterization of individual active molecules.
The value proposition lies in identifying and developing plant-derived compounds with reproducible biological activity, providing a foundation for further collaboration in natural product discovery, pharmacological evaluation, and downstream product development.
Key features:
The program is at an early research stage. Initial in vitro screening has indicated potential biological activity of the leaf extract, forming the basis for the current research hypothesis. The next planned steps are to re-establish the experimental system, conduct in vivo studies, and, if warranted, isolate and evaluate individual compounds. Further validation, characterization, and application development would be required before any commercial readiness can be considered.
Addis Ababa University is a comprehensive public research university in Ethiopia’s capital, serving a large and diverse student body across broad academic and professional programs. Industry engagement is enabled by co-located laboratories, innovation hubs and incubators, contract research mechanisms, and an engineering institute that partners on prototyping and product development. Integration with major teaching hospitals supports clinical studies and translational pathways. Research is backed by competitive national funding and international sponsors and foundations. A dedicated technology transfer office manages IP, licensing, and startup support, with industry liaison staff to streamline collaboration.